Literature DB >> 4132376

Combination CCNU and bleomycin therapy for squamous cell carcinoma.

T D Lindell, H S Moseley, W S Fletcher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4132376

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


× No keyword cloud information.
  3 in total

1.  Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal.

Authors:  N Wilking; N Petrelli; L Herrera; A Mittelman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 2.  Systemic Therapies for Advanced Squamous Cell Anal Cancer.

Authors:  Francesco Sclafani; Sheela Rao
Journal:  Curr Oncol Rep       Date:  2018-05-04       Impact factor: 5.075

3.  Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.

Authors:  Minaxi Jhawer; Sridhar Mani; Myrto Lefkopoulou; Richard G Hahn; Jules Harris; Paul J Catalano; Daniel Haller
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.